FR2062868B1 - - Google Patents

Info

Publication number
FR2062868B1
FR2062868B1 FR6931306A FR6931306A FR2062868B1 FR 2062868 B1 FR2062868 B1 FR 2062868B1 FR 6931306 A FR6931306 A FR 6931306A FR 6931306 A FR6931306 A FR 6931306A FR 2062868 B1 FR2062868 B1 FR 2062868B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR6931306A
Other languages
French (fr)
Other versions
FR2062868A1 (no
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Priority to FR6931306A priority Critical patent/FR2062868B1/fr
Priority to DE19702042504 priority patent/DE2042504B2/de
Priority to GB4384070A priority patent/GB1313150A/en
Priority to CA093,098*7A priority patent/CA963007A/en
Publication of FR2062868A1 publication Critical patent/FR2062868A1/fr
Priority to US353362A priority patent/US3894152A/en
Application granted granted Critical
Publication of FR2062868B1 publication Critical patent/FR2062868B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6931306A 1969-09-15 1969-09-15 Expired FR2062868B1 (no)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR6931306A FR2062868B1 (no) 1969-09-15 1969-09-15
DE19702042504 DE2042504B2 (de) 1969-09-15 1970-08-27 Thienyl-(3)-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
GB4384070A GB1313150A (en) 1969-09-15 1970-09-14 Amino derivatives of furane thiophene and thiazole
CA093,098*7A CA963007A (en) 1969-09-15 1970-09-14 Derives amines du furanne, du thiophene et du thiazole
US353362A US3894152A (en) 1969-09-15 1973-04-23 Use of (thienyl-3)(3-N-morpholine-propy)ketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6931306A FR2062868B1 (no) 1969-09-15 1969-09-15

Publications (2)

Publication Number Publication Date
FR2062868A1 FR2062868A1 (no) 1971-07-02
FR2062868B1 true FR2062868B1 (no) 1973-08-10

Family

ID=9040074

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6931306A Expired FR2062868B1 (no) 1969-09-15 1969-09-15

Country Status (4)

Country Link
CA (1) CA963007A (no)
DE (1) DE2042504B2 (no)
FR (1) FR2062868B1 (no)
GB (1) GB1313150A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1151164A (en) * 1978-01-13 1983-08-02 Atsuyuki Kojima Conjugated ketone compounds and their production and use
FR2453172A1 (fr) * 1979-04-06 1980-10-31 Innothera Lab Sa Nouvelles (thienyl-2) amino-1 butyl cetones, leur procede de preparation et leur application en therapeutique
DE3661917D1 (en) * 1985-03-20 1989-03-02 Ferrer Int Thiophene ring-substituted alpha-(alkylaminopropionyl)-thiophene derivatives, a process for preparing them and pharmaceutical compositions containing them
ES8707505A2 (es) * 1986-06-03 1987-08-01 Ferrer Int Mejoras en el objeto de la patente de invencion n.541.911 por procedimiento de obtencion de nuevos derivados de alfa-(alquilaminopropionil)-tiofeno sustituidos en el anillo tiofenico
DK2482815T3 (en) * 2009-10-02 2018-06-06 Avexxin As ANTI-INFLAMMATORY 2-OXOTHIAZOLES AND 2-OXOOXAZOLES
CN110128370A (zh) 2013-01-29 2019-08-16 埃维克辛公司 抗炎症和抗肿瘤的2-氧代噻唑类和2-氧代噻吩类化合物
GB201413695D0 (en) 2014-08-01 2014-09-17 Avexxin As Compound
GB201604318D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1214077A (en) * 1967-11-02 1970-12-02 Usv Pharma Corp Oximes and their carbamoyl esters and the methods of preparation thereof

Also Published As

Publication number Publication date
CA963007A (en) 1975-02-18
DE2042504C3 (no) 1973-12-06
FR2062868A1 (no) 1971-07-02
DE2042504A1 (de) 1971-04-01
GB1313150A (en) 1973-04-11
DE2042504B2 (de) 1973-05-10

Similar Documents

Publication Publication Date Title
AU2270770A (no)
AU465452B2 (no)
AU429630B2 (no)
AU450150B2 (no)
AU2355770A (no)
AU442375B2 (no)
AU427401B2 (no)
AU470301B1 (no)
AU442463B2 (no)
AU414607B2 (no)
AU428129B2 (no)
AU428131B2 (no)
AU425297B2 (no)
AT308690B (no)
AU438128B2 (no)
AU470661B1 (no)
AU442285B2 (no)
AU442322B2 (no)
AU442357B2 (no)
AU417208B2 (no)
AU442380B2 (no)
AU410358B2 (no)
AU442535B2 (no)
AU442538B2 (no)
AU442554B2 (no)

Legal Events

Date Code Title Description
ST Notification of lapse